Get the Stockscreener App
7.275
2.09%
-0.155
Immatics N V stock is traded at $7.275, with a volume of 516.21K.
It is down -2.09% in the last 24 hours and down -17.24% over the past month.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$7.43
Open:
$7.41
24h Volume:
516.21K
Relative Volume:
0.50
Market Cap:
$1.11B
Revenue:
$43.34M
Net Income/Loss:
$-247.99M
P/E Ratio:
-3.6858
EPS:
-1.9738
Net Cash Flow:
$-224.28M
1W Performance:
-5.89%
1M Performance:
-17.24%
6M Performance:
-30.25%
1Y Performance:
-29.78%
1-Day Range:
$7.14
$7.42
1-Week Range:
$7.02
$7.81
52-Week Range:
$7.02
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
7.275 | 1.11B | 43.34M | -247.99M | -224.28M | -1.9738 |
VRTX
Vertex Pharmaceuticals Inc
|
508.18 | 128.80B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
212.45 | 84.82B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
765.73 | 78.84B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.73 | 51.49B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.48 | 41.47B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-28-26 | Initiated | TD Cowen | Buy |
| Mar-16-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Immatics (IMTX) Slides 10% as Shares Test Key Support Near $7.21Chaikin Flow - siam.in
Immatics (NASDAQ:IMTX) Sets New 52-Week LowHere's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Shares Down 5.3%Here's What Happened - marketbeat.com
Immatics (Nasdaq:IMTX)Stock Analysis - Simply Wall Street
Immatics (NASDAQ:IMTX) Sees Unusually-High Trading VolumeStill a Buy? - marketbeat.com
Immatics (NASDAQ:IMTX) Stock Rating Upgraded by Wall Street Zen - marketbeat.com
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeWhat's Next? - marketbeat.com
Immatics stock falls 3.04 percent after cash raise and Q2 miss - AD HOC NEWS
Immatics N.V. (NASDAQ:IMTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (IMTX) for Rule-Based Strategy - Stock Traders Daily
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportShort Term Trading Ideas - vinanet.vn
Immatics stock holds near USD 9.60 after market cap update - ad-hoc-news.de
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportHigh Reward Trades - dars.gov.et
Immatics N.V. Warrants (IMTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Immatics (NASDAQ:IMTX) Shares Up 5.3% on Insider Buying Activity - MarketBeat
Insider Buying: Immatics (NASDAQ:IMTX) Director Purchases 863,060 Shares of Stock - MarketBeat
Perceptive fund boosts Immatics (IMTX) stake with new open-market share buy - Stock Titan
Perceptive Advisors Acquires 863,060 Shares of Immatics N.V. at $8.69 Each - Kalkine Media
Immatics (NASDAQ: IMTX) gets 863K-share buy at $8.69 from Perceptive - Stock Titan
Trading Systems Reacting to (IMTX) Volatility - Stock Traders Daily
Immatics (NASDAQ: IMTX) raises fresh cash to fund oncology pipeline - Stock Titan
Form 424B2 Immatics N.V. - StreetInsider
Why is Immatics stock climbing today? - Investing.com India
Why is Immatics stock climbing today? By Investing.com - Investing.com Nigeria
Why is Immatics stock climbing today? By Investing.com - Investing.com UK
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma - Seeking Alpha
Immatics Announces $150 Million Underwritten Offering - GlobeNewswire
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Why Immatics (IMTX) Is Down 5.4% After Mixed First‑Half 2026 Loss Trends And What's Next - simplywall.st
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
James Nelson Pepin Net Worth (2026) - GuruFocus
Immatics (NASDAQ:IMTX) Shares Down 8%Should You Sell? - MarketBeat
Immatics Announces Second Quarter 2026 Financial Results and Business Update - Sahm
Immatics (IMTX) awards counsel Nelson 225K share package - Stock Titan
Immatics Releases Q2 2026 Financial Results - AlphaStreet
Immatics Q2 revenue rises to $10.4 million - grafa.com
Immatics earnings on deck as analysts eye revenue trajectory By Investing.com - Investing.com India
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics Q2 Results: EPS misses estimate, sales up 93% YoY - scanx.trade
IMTX Looks 176.9% Overvalued on GF Value™ - GuruFocus
Immatics (NASDAQ:IMTX) Issues Earnings Results - MarketBeat
Immatics (IMTX) Slides 2.01% as Shares Approach Key $8.79 Support LevelQuality Factor - Vinanet
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials - TipRanks
Immatics' Q2 Net Loss Narrows as Revenue Rises - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, vs. FactSet Est of 10.4M Euros - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Net Loss 0.46 Euros a Share, vs. FactSet Est of 0.45 Euros Loss - marketscreener.com
Immatics reports Q2 EPS (46c), consensus (48c) - TipRanks
Immatics: Q2 Earnings Snapshot - marketscreener.com
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.50%
8.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):